Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft

Transplantation

Volumn 62, Issue 10, 1996, Pages 1462-1468

  Wong, Wilson ^a   Morris, Peter J ^a   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029853246     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611270-00014     Document Type: Article

References (38)

1. Kashiwagi N, Porter KA, Penn I, Brettschneider L, Starzl TE. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum 1969; 20: 374.
2. Starzl TE. Cell migration and chimerism - a unifying concept in transplantation-with particular reference to HLA matching and tolerance induction. Transplant Proc 1993; 25: 8.
3. Morahan G, Allison J, Miller JF. Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 1989; 339: 622.
4. Ramsdell F, Fowlkes BJ. Maintenance of in vivo tolerance by persistence of antigen. Science 1992; 257: 1130.
5. Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts. Transplant Proc 1995; 27: 151.
6. Stewart FM, Crittenden RB, Lowry PA, Pearson WS, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993; 81: 2566.
7. Jacobsen N, Taaning E, Ladefoged J, Kristensen JK, Pedersen FK. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 1994; 343: 800.
8. Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilnney NL. Immunologic tolerance to renal allografts after bone marrow transplants form the same donors. Ann Intern Med 1991; 114: 954.
9. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal perparative regimen. J Exp Med 1989; 169: 493.
10. Sharabi Y, Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992; 9: 191.
11. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994; 83: 939.
12. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986; 323: 164.
13. Wood ML, Monaco AP, Gozzo JJ, Liegeois A. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1971; 3: 676.
14. Thomas JM, Carver FM, Cunningham PR, Olson LC, Thomas FT. Kidney allograft tolerance in primates without chronic immunosuppression - the role of veto cells. Transplantation 1991; 51: 198.
15. Thomas JM, Verbanac KM, Smith JP, et al. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995; 59: 245.
16. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
17. Clift RA, Storb R. Histoincompatible bone marrow transplants in humans. Annu Rev Immunol 1987; 5: 43.
18. Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 1987; 17: 1159.
19. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
20. Superina RA, Peugh WN, Wood KJ, Morris PJ. Assessment of primarily vascularized cardiac allografts in mice. Transplantation 1986; 42: 226.
21. Husbands SD, Schonrich G, Arnold B, et al. Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via a non-deletional mechanism. Eur J Immunol 1992; 22: 2655.
22. Bushell A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ cell regulation during the induction phase of the response. Eur J Immunol 1995; 25: 2643.
23. Ockner SA, Guttmann RD, Lindquist RR. Renal transplantation in the inbred rat: XIII. Modification of rejection by active immunization with bone marrow cells. Transplantation 1970; 9:30.
24. Qin SX, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 779.
25. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 1087.
26. Sykes M, Sachs DH, Nienhuis AW, Pearson DA, Moulton AD, Bodine DM. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993; 55: 197.
27. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
28. Saitovitch D, Morris PJ, Wood KJ. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody: evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules. Transplantation (in press).
29. Qian S, Li FY, Lu L, Noyola H, Rao AS, Thomson AW. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Immunology 1995; 85: 82.
30. Holan V, Mitchison NA. Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens. Eur. J Immunol 1983; 13: 652.
31. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264: 1587.
32. Ohlen C, Kling G, Hoglund P, et al. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 1989; 246: 666.
33. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991; 349: 329.
34. Ishida T, Inaba M, Hisha H, et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994; 152: 3119.
35. Hisha H, Nishino T, Kawamura M, Adachi S, Ikehara S. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 1995; 23: 347.
36. Harrison DE. Competitive repopulation in unirradiated normal recipients. Blood 1993; 81: 2473.
37. Raudrant D, Touraine JL, Rebaud A. In utero transplantation of stem cells in humans: technical aspects and clinical experience during pregnancy. Bone Marrow Transplant 1992; 1: 98.
38. Wu DD, Keating A. Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol 1993; 21: 251.